CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,072,960
- in 74 filings, $341.3M under 10b5-1 plans
Net −$342,072,960. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-26 | EDGEMOND JAMES CFO AND TREASURER | Option exercise 10b5-1 | +10,000 | $117.76 | $1.2M | 28,876 |
| 2026-05-26 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −25 | $559.58 | $14K | 28,851 |
| 2026-05-26 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −135 | $561.21 | $76K | 28,716 |
| 2026-05-26 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −280 | $564.02 | $158K | 28,436 |
| 2026-05-26 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −240 | $566.37 | $136K | 28,196 |
| 2026-05-26 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −520 | $567.36 | $295K | 27,676 |
| 2026-05-26 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,040 | $568.54 | $591K | 26,636 |
| 2026-05-26 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −760 | $569.79 | $433K | 25,876 |
| 2026-05-26 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −700 | $570.92 | $400K | 25,176 |
| 2026-05-26 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −860 | $571.93 | $492K | 24,316 |
| 2026-05-26 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −440 | $572.70 | $252K | 23,876 |
| 2026-05-26 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −281 | $574.13 | $161K | 23,595 |
| 2026-05-26 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −809 | $575.24 | $465K | 22,786 |
| 2026-05-26 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,221 | $576.21 | $704K | 21,565 |
| 2026-05-26 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,929 | $577.13 | $1.1M | 19,636 |
| 2026-05-26 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −760 | $578.12 | $439K | 18,876 |
| 2026-05-26 | EDGEMOND JAMES CFO AND TREASURER | Option exercise · Stock Option 10b5-1 | −10,000 | 60,000 | ||
| 2026-05-26 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-05-26 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −45 | $560.52 | $25K | 49,968 |
| 2026-05-26 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −35 | $560.74 | $20K | 49,933 |
Page 95 of 120 · 2,391 trades